List of causes of death by rate

The following is a list of the causes of human deaths worldwide for different years arranged by their associated mortality rates. There were 57,029,000 deaths tabulated in 2002. Some causes listed include deaths also included in more specific subordinate causes (as indicated by the "Group" column), and some causes are omitted, so the percentages do not sum to 100. According to the World Health Organization, about 58 million people died in 2005, using the International Statistical Classification of Diseases and Related Health Problems (ICD).[1] According to the Institute for Health Metrics and Evaluation, 52.77 million people died in 2010.[2]

Leading cause of death (2016) (world)

The causes listed are relatively immediate medical causes, but the ultimate cause of death might be described differently. For example, tobacco smoking can cause lung disease or cancer, and alcohol abuse can cause liver failure or a motor vehicle accident. For statistics on preventable ultimate causes, see preventable causes of death.

By frequency

Age standardized death rate, per 100,000, by cause, in 2017, and percentage change 2007–2017.[3]

Age-standardised Death Rate (per 100,000) in 2017
CauseRatePercent of all deathsPercent Change 2007–2017
All causes737.7
(729.9 to 745.4)
100%-14.2
(-15.0 to -13.5)
Communicable, maternal, neonatal, and nutritional disorders143.8
(138.4 to 151.6)
19.49%-31.8
(-33.3 to -30.1)
HIV/AIDS and sexually transmitted infections13.9
(12.6 to 15.5)
1.88%-53.6
(-55.8 to -51.0)
HIV/AIDS 12.1
(11.5 to 12.9)
1.64%-56.5
(-58.0 to -54.7)
HIV/AIDS – Drug-susceptible Tuberculosis2.5
(1.8 to 3.2)
0.34%-61.1
(-63.7 to -57.7)
HIV/AIDS – Multidrug-resistant Tuberculosis without extensive drug resistance0.3
(0.2 to 0.4)
0.04%-58.1
(-70.5 to -41.5)
HIV/AIDS – Extensively drug-resistant Tuberculosis0.0
(0.0 to 0.0)
0.00%-20.3
(-36.4 to -0.2)
HIV/AIDS resulting in other diseases9.3
(8.4 to 10.4)
1.26%-55.1
(-57.2 to -52.6)
Sexually transmitted infections excluding HIV 1.8
(0.7 to 3.3)
0.24%-14.4
(-21.5 to -6.6)
Syphilis1.7
(0.7 to 3.2)
0.23%-14.3
(-21.8 to -6.4)
Chlamydial infection0.0
(0.0 to 0.0)
0.00%-15.2
(-21.0 to -8.4)
Gonococcal infection0.0
(0.0 to 0.0)
0.00%-14.9
(-20.8 to -8.2)
Other sexually transmitted infections0.0
(0.0 to 0.0)
0.00%-15.9
(-21.6 to -9.5)
Respiratory infections and tuberculosis50.5
(48.8 to 52.3)
6.85%-24.5
(-26.4 to -22.6)
Tuberculosis 14.9
(14.3 to 15.7)
2.02%-31.4
(-34.1 to -27.6)
Drug-susceptible tuberculosis13.2
(12.0 to 14.2)
1.79%-31.9
(-37.3 to -26.4)
Multidrug-resistant tuberculosis without extensive drug resistance1.6
(0.9 to 2.5)
0.22%-28.6
(-57.4 to 11.4)
Extensively drug-resistant tuberculosis0.2
(0.1 to 0.2)
0.03%-7.7
(-34.1 to 28.8)
Lower respiratory infections 35.4
(33.8 to 36.8)
4.80%-21.1
(-23.2 to -18.9)
Upper respiratory infections 0.1
(0.1 to 0.2)
0.01%-42.1
(-49.6 to -29.9)
Otitis media 0.0
(0.0 to 0.0)
0.00%-50.4
(-58.8 to -39.9)
Enteric infections24.4
(19.5 to 32.4)
3.31%-29.9
(-34.9 to -23.1)
Diarrhoeal diseases21.6
(16.4 to 29.7)
2.93%-30.2
(-36.1 to -22.7)
Typhoid and paratyphoid1.9
(1.1 to 3.0)
0.26%-27.8
(-32.8 to -23.9)
(Typhoid fever)1.6
(0.9 to 2.6)
0.22%-29.1
(-34.1 to -25.0)
(Paratyphoid fever)0.3
(0.1 to 0.5)
0.04%-18.9
(-26.1 to -10.8)
iNTS0.8
(0.5 to 1.4)
0.11%-24.8
(-31.9 to -15.6)
Other intestinal infectious diseases0.0
(0.0 to 0.0)
0.00%-44.7
(-70.1 to 2.3)
Neglected tropical diseases and malaria10.1
(7.5 to 13.2)
1.37%-36.1
(-43.7 to -27.3)
Malaria8.7
(6.1 to 11.9)
1.18%-37.3
(-45.4 to -27.9)
Chagas disease0.1
(0.1 to 0.1)
0.01%-21.1
(-25.2 to -14.3)
Leishmaniasis0.1
(0.0 to 0.5)
0.01%-67.8
(-97.5 to -50.3)
(Visceral leishmaniasis)0.1
(0.0 to 0.5)
0.01%-67.8
(-97.5 to -50.3)
African trypanosomiasis (sleeping sickness)0.0
(0.0 to 0.1)
0.00%-82.8
(-96.0 to -34.3)
Schistosomiasis0.1
(0.1 to 0.1)
0.01%-28.5
(-32.7 to -23.7)
Cysticercosis0.0
(0.0 to 0.0)
0.00%-27.3
(-50.5 to 5.3)
Cystic echinococcosis0.0
(0.0 to 0.0)
0.00%-41.9
(-59.8 to -19.0)
Dengue0.5
(0.2 to 0.7)
0.07%40.7
(3.6 to 69.7)
Yellow fever0.1
(0.0 to 0.2)
0.01%-23.3
(-34.4 to -9.6)
Rabies0.2
(0.1 to 0.2)
0.03%-54.8
(-63.8 to -45.0)
Intestinal nematode infections0.0
(0.0 to 0.1)
0.00%-47.2
(-59.5 to -30.1)
(Ascariasis)0.0
(0.0 to 0.1)
0.00%-47.2
(-59.5 to -30.1)
Ebola virus disease0.0
(0.0 to 0.0)
0.00%-98.4
(-98.4 to -98.4)
Zika virus disease0.0
(0.0 to 0.0)
0.00%-
Other neglected tropical diseases0.2
(0.1 to 0.5)
0.03%-3.7
(-18.3 to 13.9)
Other infectious diseases11.6
(10.1 to 13.3)
1.57%-33.8
(-39.3 to -27.4)
Meningitis 4.0
(3.6 to 4.6)
0.54%-27.8
(-33.1 to -19.3)
Pneumococcal meningitis0.6
(0.5 to 0.7)
0.08%-22.4
(-28.9 to -12.4)
H influenzae type B meningitis1.1
(0.9 to 1.3)
0.15%-40.6
(-45.8 to -33.9)
Meningococcal infection0.4
(0.4 to 0.5)
0.05%-37.1
(-42.6 to -29.2)
Other meningitis2.0
(1.7 to 2.3)
0.27%-17.3
(-23.4 to -7.5)
Encephalitis 1.2
(1.1 to 1.4)
0.16%-14.3
(-26.5 to -0.9)
Diphtheria 0.1
(0.0 to 0.1)
0.01%-28.6
(-58.8 to 29.2)
Whooping cough (pertussis) 1.4
(0.7 to 2.4)
0.19%-27.1
(-57.1 to 28.8)
Tetanus 0.5
(0.4 to 0.7)
0.07%-59.6
(-69.3 to -45.0)
Measles 1.4
(0.5 to 3.1)
0.19%-59.3
(-64.0 to -54.4)
Varicella (chickenpox) and herpes zoster (shingles) 0.2
(0.2 to 0.2)
0.03%-29.2
(-34.7 to -23.4)
Acute hepatitis 1.6
(1.2 to 1.9)
0.22%-24.5
(-29.2 to -18.4)
Acute hepatitis A0.3
(0.2 to 0.3)
0.04%-38.7
(-46.8 to -28.6)
Acute hepatitis B1.1
(0.8 to 1.3)
0.15%-19.6
(-25.4 to -12.4)
Acute hepatitis C0.0
(0.0 to 0.1)
0.00%-32.1
(-42.4 to -19.6)
Acute hepatitis E0.2
(0.1 to 0.2)
0.03%-25.8
(-35.3 to -15.6)
Other unspecified infectious diseases 1.1
(0.8 to 1.2)
0.15%-13.4
(-17.5 to -8.1)
Maternal and neonatal disorders29.5
(28.2 to 30.8)
4.00%-26.6
(-29.3 to -23.5)
Maternal disorders 2.5
(2.3 to 2.7)
0.34%-30.7
(-34.8 to -26.6)
Maternal haemorrhage0.5
(0.4 to 0.6)
0.07%-56.4
(-62.7 to -49.3)
Maternal sepsis and other pregnancy related infections
(e.g. Postpartum infections)
0.3
(0.2 to 0.3)
0.04%-33.5
(-44.2 to -22.6)
Maternal hypertensive disorders0.4
(0.3 to 0.4)
0.05%-13.0
(-27.3 to 2.6)
Maternal obstructed labour and uterine rupture0.2
(0.1 to 0.2)
0.03%-25.2
(-41.0 to -6.3)
Maternal abortive outcome0.2
(0.2 to 0.3)
0.03%-15.7
(-29.3 to -0.4)
Ectopic pregnancy0.1
(0.1 to 0.2)
0.01%-19.2
(-46.2 to 16.8)
Indirect maternal deaths0.4
(0.4 to 0.5)
0.05%-12.5
(-24.0 to -1.0)
Late maternal deaths0.0
(0.0 to 0.1)
0.00%-9.5
(-14.7 to -4.0)
Maternal deaths aggravated by HIV/AIDS0.0
(0.0 to 0.0)
0.00%-32.1
(-38.4 to -25.2)
Other maternal disorders0.3
(0.3 to 0.4)
0.04%-16.5
(-31.2 to 1.5)
Neonatal disorders 27.1
(25.8 to 28.3)
3.67%-26.2
(-29.1 to -22.7)
Neonatal preterm birth9.9
(9.2 to 10.9)
1.34%-28.1
(-33.2 to -23.6)
Neonatal encephalopathy due to birth asphyxia and trauma8.1
(7.2 to 8.8)
1.10%-26.5
(-32.0 to -20.2)
Neonatal sepsis and other neonatal infections3.1
(2.7 to 4.1)
0.42%-14.4
(-22.7 to -4.4)
Hemolytic disease and other neonatal jaundice0.7
(0.7 to 0.8)
0.09%-39.3
(-46.8 to -30.2)
Other neonatal disorders5.3
(4.5 to 5.8)
0.72%-25.7
(-31.7 to -17.8)
Nutritional deficiencies3.8
(3.5 to 4.2)
0.52%-33.6
(-38.1 to -26.5)
Protein-energy malnutrition3.3
(3.0 to 3.7)
0.45%-34.6
(-39.4 to -27.5)
Other nutritional deficiencies0.5
(0.4 to 0.6)
0.07%-25.8
(-31.7 to -17.5)
Non-communicable diseases536.1
(528.4 to 542.2)
72.67%-7.9
(-8.8 to -7.0)
Neoplasms121.2
(119.1 to 122.9)
16.43%-4.4
(-5.6 to -3.3)
Lip and oral cavity cancer2.4
(2.3 to 2.5)
0.33%4.0
(-0.6 to 8.0)
Nasopharynx cancer0.9
(0.8 to 0.9)
0.12%-3.0
(-6.4 to 0.4)
Other pharynx cancer1.4
(1.3 to 1.5)
0.19%7.9
(-0.3 to 14.0)
Oesophageal cancer5.5
(5.3 to 5.6)
0.75%-14.5
(-16.9 to -12.0)
Stomach cancer11.0
(10.8 to 11.2)
1.49%-17.1
(-18.8 to -15.1)
Colon and rectum cancer11.5
(11.3 to 11.8)
1.56%-4.3
(-7.1 to -1.8)
Liver cancer10.2
(9.8 to 10.7)
1.38%-2.5
(-5.6 to 2.0)
(Liver cancer due to hepatitis B)4.0
(3.7 to 4.3)
0.54%-6.2
(-10.0 to 0.1)
(Liver cancer due to hepatitis C)3.0
(2.8 to 3.2)
0.41%-2.1
(-4.9 to 1.4)
(Liver cancer due to alcohol use)1.6
(1.4 to 1.8)
0.22%0.6
(-3.0 to 4.8)
(Liver cancer due to NASH)0.8
(0.8 to 0.9)
0.11%7.6
(4.4 to 11.7)
(Liver cancer due to other causes)0.8
(0.7 to 0.9)
0.11%-0.9
(-4.2 to 3.6)
Gallbladder and biliary tract cancer2.2
(2.0 to 2.4)
0.30%-6.7
(-9.4 to -4.0)
Pancreatic cancer5.6
(5.5 to 5.7)
0.76%4.8
(2.5 to 6.8)
Larynx cancer1.6
(1.5 to 1.6)
0.22%-7.7
(-10.1 to -5.2)
Tracheal, bronchus, and lung cancer23.7
(23.3 to 24.2)
3.21%-2.0
(-4.3 to 0.1)
Malignant skin melanoma0.8
(0.6 to 0.9)
0.11%-5.1
(-8.5 to -2.5)
Non-melanoma skin cancer0.8
(0.8 to 0.9)
0.11%2.7
(0.0 to 4.5)
(Non-melanoma skin cancer (squamous-cell carcinoma))0.8
(0.8 to 0.9)
0.11%2.7
(0.0 to 4.5)
Breast cancer7.6
(7.4 to 8.0)
1.03%-2.6
(-6.9 to 0.4)
Cervical cancer3.2
(3.0 to 3.3)
0.43%-7.2
(-11.7 to -4.0)
Uterine cancer1.1
(1.0 to 1.1)
0.15%-10.4
(-12.5 to -7.7)
Ovarian cancer2.2
(2.1 to 2.3)
0.30%-1.0
(-3.6 to 1.6)
Prostate cancer5.5
(4.7 to 6.5)
0.75%-2.5
(-4.9 to 1.9)
Testicular cancer0.1
(0.1 to 0.1)
0.01%-9.4
(-12.6 to -5.2)
Kidney cancer1.8
(1.6 to 1.8)
0.24%-1.3
(-4.3 to 1.7)
Bladder cancer2.6
(2.5 to 2.7)
0.35%-5.4
(-7.3 to -3.4)
Brain and nervous system cancer3.1
(2.7 to 3.3)
0.42%3.8
(-1.0 to 7.0)
Thyroid cancer0.5
(0.5 to 0.6)
0.07%-1.2
(-4.5 to 2.0)
Mesothelioma0.4
(0.4 to 0.4)
0.05%-3.4
(-8.4 to 0.7)
Hodgkin lymphoma0.4
(0.4 to 0.5)
0.05%-16.8
(-19.8 to -14.0)
Non-Hodgkin's lymphoma3.2
(3.1 to 3.2)
0.43%0.1
(-2.7 to 2.4)
Multiple myeloma1.4
(1.3 to 1.5)
0.19%-0.4
(-3.5 to 2.4)
Leukaemia 4.5
(4.1 to 4.7)
0.61%-9.6
(-12.2 to -7.4)
Acute lymphoid leukaemia0.7
(0.6 to 0.7)
0.09%-1.5
(-11.6 to 6.2)
Chronic lymphoid leukaemia0.5
(0.4 to 0.5)
0.07%-10.3
(-13.0 to -7.6)
Acute myeloid leukaemia1.3
(1.2 to 1.3)
0.18%-1.0
(-6.6 to 3.0)
Chronic myeloid leukaemia0.3
(0.3 to 0.3)
0.04%-19.9
(-22.2 to -17.6)
Other leukaemia1.8
(1.6 to 1.9)
0.24%-15.6
(-18.7 to -12.1)
Other malignant cancers 4.6
(4.2 to 4.8)
0.62%0.1
(-2.6 to 2.2)
Other neoplasms 1.3
(1.0 to 1.6)
0.18%7.4
(2.1 to 15.8)
Myelodysplastic, myeloproliferative, and other hematopoietic neoplasms1.3
(1.0 to 1.5)
0.18%7.1
(1.8 to 15.3)
Other benign and in situ neoplasms0.1
(0.0 to 0.1)
0.01%15.5
(4.1 to 29.2)
Cardiovascular diseases233.1
(229.7 to 236.4)
31.60%-10.3
(-11.4 to -9.3)
Rheumatic heart disease3.7
(3.4 to 3.9)
0.50%-21.3
(-25.2 to -17.8)
Ischaemic heart disease116.9
(115.1 to 119.7)
15.85%-9.7
(-11.0 to -8.7)
Stroke 80.5
(78.9 to 82.6)
10.91%-13.6
(-15.0 to -12.1)
Ischaemic stroke36.6
(35.5 to 38.0)
4.96%-11.8
(-13.4 to -10.3)
Intracerebral hemorrhage38.2
(37.0 to 39.4)
5.18%-15.7
(-17.8 to -13.8)
Subarachnoid hemorrhage5.7
(5.3 to 6.3)
0.77%-9.4
(-13.1 to -4.9)
Hypertensive heart disease 12.3
(9.0 to 13.2)
1.67%7.5
(-7.3 to 16.3)
Non-rheumatic valvular heart disease 2.0
(1.6 to 2.0)
0.27%-5.3
(-7.9 to -3.2)
Non-rheumatic calcific aortic valve disease1.4
(1.1 to 1.5)
0.19%-1.0
(-5.6 to 2.2)
Non-rheumatic degenerative mitral valve disease0.5
(0.4 to 0.6)
0.07%-14.0
(-18.1 to -8.6)
Other non-rheumatic valve diseases0.1
(0.1 to 0.1)
0.01%-17.8
(-28.5 to 8.0)
Cardiomyopathy and myocarditis 4.8
(4.5 to 5.0)
0.65%-16.6
(-19.8 to -9.4)
Myocarditis0.6
(0.5 to 0.7)
0.08%-13.3
(-20.4 to -0.1)
Alcoholic cardiomyopathy1.1
(1.0 to 1.2)
0.15%-40.5
(-43.7 to -27.6)
Other cardiomyopathy3.1
(2.8 to 3.3)
0.42%-3.6
(-6.7 to -0.7)
Atrial fibrillation and flutter 4.0
(3.9 to 4.2)
0.54%2.6
(0.9 to 4.6)
Aortic aneurysm 2.2
(2.1 to 2.3)
0.30%-8.5
(-11.2 to -5.8)
Peripheral vascular disease 1.0
(0.6 to 1.7)
0.14%10.5
(-6.8 to 24.1)
Endocarditis 1.1
(1.0 to 1.2)
0.15%1.0
(-4.0 to 5.0)
Other cardiovascular and circulatory diseases 4.7
(4.4 to 5.1)
0.64%-7.9
(-10.9 to -5.9)
Chronic respiratory diseases51.4
(49.7 to 53.1)
6.97%-14.2
(-16.5 to -11.5)
Chronic obstructive pulmonary disease42.2
(40.0 to 44.2)
5.72%-13.6
(-16.5 to -11.0)
Pneumoconiosis0.3
(0.3 to 0.3)
0.04%-16.7
(-20.8 to -12.4)
(Silicosis)0.1
(0.1 to 0.2)
0.01%-15.5
(-23.6 to -7.4)
(Asbestosis)0.0
(0.0 to 0.1)
0.00%-8.3
(-14.1 to -0.4)
(Coal workers pneumoconiosis)0.0
(0.0 to 0.1)
0.00%-26.6
(-33.8 to -16.7)
(Other pneumoconiosis)0.0
(0.0 to 0.1)
0.00%-17.5
(-24.1 to -5.0)
Asthma6.3
(4.3 to 8.2)
0.85%-23.9
(-28.1 to -17.2)
Interstitial lung disease and pulmonary sarcoidosis1.9
(1.5 to 2.4)
0.26%11.4
(4.0 to 17.9)
Other chronic respiratory diseases0.7
(0.6 to 0.8)
0.09%-3.2
(-8.7 to 6.7)
Digestive diseases30.3
(29.2 to 32.1)
4.11%-10.7
(-13.1 to -7.3)
Cirrhosis and other chronic liver diseases 16.5
(15.8 to 18.1)
2.24%-9.7
(-14.7 to -4.6)
Cirrhosis and other chronic liver diseases due to hepatitis B4.8
(4.3 to 5.5)
0.65%-14.3
(-20.2 to -7.3)
Cirrhosis and other chronic liver diseases due to hepatitis C4.2
(3.9 to 4.7)
0.57%-8.4
(-13.0 to -3.9)
Cirrhosis and other chronic liver diseases due to alcohol use4.1
(3.7 to 4.6)
0.56%-8.8
(-13.2 to -3.4)
Cirrhosis due to NASH1.5
(1.3 to 1.6)
0.20%-1.4
(-6.3 to 3.1)
Cirrhosis and other chronic liver diseases due to other causes1.9
(1.7 to 2.1)
0.26%-8.6
(-13.4 to -3.8)
Upper digestive system diseases 3.8
(3.6 to 4.0)
0.52%-21.6
(-24.8 to -17.3)
Peptic ulcer disease3.1
(3.0 to 3.3)
0.42%-23.5
(-26.6 to -19.7)
Gastritis and duodenitis0.7
(0.6 to 0.7)
0.09%-11.7
(-17.6 to -2.2)
Appendicitis 0.6
(0.5 to 0.6)
0.08%-17.0
(-21.5 to -10.7)
Paralytic ileus and intestinal obstruction 3.2
(2.7 to 3.5)
0.43%-5.8
(-11.0 to 0.3)
Inguinal, femoral, and abdominal hernia 0.6
(0.5 to 0.7)
0.08%-8.9
(-12.9 to -4.2)
Inflammatory bowel disease 0.5
(0.4 to 0.5)
0.07%-10.5
(-16.0 to -5.9)
Vascular intestinal disorders 1.3
(1.2 to 1.3)
0.18%-10.2
(-14.2 to -6.2)
Gallbladder and biliary diseases 1.5
(1.4 to 1.6)
0.20%-5.0
(-7.5 to -1.7)
Pancreatitis 1.3
(1.1 to 1.4)
0.18%-5.7
(-9.0 to -1.7)
Other digestive diseases 1.2
(1.1 to 1.2)
0.16%-7.1
(-12.1 to -2.4)
Neurological disorders43.1
(42.3 to 43.7)
5.84%0.1
(-1.2 to 1.3)
Alzheimer's disease and other dementias35.4
(34.8 to 35.9)
4.80%0.6
(-0.9 to 1.8)
Parkinson's disease4.6
(4.4 to 4.8)
0.62%0.8
(-2.8 to 3.0)
Epilepsy1.7
(1.5 to 2.0)
0.23%-10.7
(-15.4 to -0.5)
Multiple sclerosis0.3
(0.2 to 0.3)
0.04%-3.9
(-14.5 to 0.4)
Motor neuron disease0.4
(0.4 to 0.5)
0.05%1.2
(-2.4 to 4.5)
Other neurological disorders0.7
(0.7 to 0.8)
0.09%2.0
(-3.9 to 6.8)
Mental disorders0.0
(0.0 to 0.0)
0.00%7.5
(-1.4 to 15.9)
Eating disorders 0.0
(0.0 to 0.0)
0.00%7.5
(-1.4 to 15.9)
Anorexia nervosa0.0
(0.0 to 0.0)
0.00%5.5
(-4.1 to 14.4)
Bulimia nervosa0.0
(0.0 to 0.0)
0.00%13.5
(1.0 to 26.2)
Substance use disorders4.3
(4.1 to 4.5)
0.58%2.0
(-1.0 to 5.0)
Alcohol use disorders 2.3
(2.0 to 2.4)
0.31%-16.5
(-20.4 to -12.4)
Drug use disorders 2.1
(2.0 to 2.1)
0.28%34.1
(31.4 to 36.9)
Opioid use disorders1.4
(1.3 to 1.4)
0.19%49.4
(42.5 to 59.2)
Cocaine use disorders0.1
(0.1 to 0.1)
0.01%19.6
(9.2 to 33.0)
Amphetamine use disorders0.1
(0.0 to 0.1)
0.01%8.7
(-14.0 to 20.7)
Other drug use disorders0.6
(0.5 to 0.6)
0.08%11.3
(1.2 to 19.9)
Diabetes and kidney diseases33.6
(32.9 to 34.3)
4.55%1.3
(-0.3 to 2.7)
Diabetes mellitus 17.5
(17.1 to 17.9)
2.37%1.2
(-0.7 to 3.1)
Diabetes mellitus type 14.3
(4.0 to 4.7)
0.58%-11.0
(-14.6 to -7.8)
Diabetes mellitus type 213.2
(12.7 to 13.7)
1.79%5.9
(4.1 to 8.0)
Chronic kidney disease 15.9
(15.5 to 16.3)
2.16%1.5
(-0.9 to 3.2)
Chronic kidney disease due to diabetes mellitus type 10.9
(0.8 to 1.2)
0.12%-1.2
(-4.0 to 1.2)
Chronic kidney disease due to diabetes mellitus type 24.5
(4.0 to 5.1)
0.61%4.2
(1.4 to 6.2)
Chronic kidney disease due to hypertension4.6
(4.0 to 5.2)
0.62%3.2
(0.4 to 5.2)
Chronic kidney disease due to glomerulonephritis2.4
(2.1 to 2.8)
0.33%-1.3
(-3.2 to 0.7)
Chronic kidney disease due to other and unspecified causes3.4
(3.0 to 3.9)
0.46%-1.4
(-3.7 to 0.6)
Acute glomerulonephritis 0.1
(0.1 to 0.2)
0.01%-9.5
(-14.5 to -3.5)
Skin and subcutaneous diseases1.3
(0.9 to 1.7)
0.18%8.1
(2.7 to 16.5)
Bacterial skin diseases1.0
(0.6 to 1.3)
0.14%12.7
(6.0 to 20.7)
(Cellulitis0.2
(0.1 to 0.3)
0.03%19.6
(9.8 to 28.2)
(Pyoderma0.8
(0.5 to 0.9)
0.11%10.5
(3.2 to 19.0)
Decubitus ulcer0.3
(0.2 to 0.4)
0.04%-5.1
(-12.2 to 9.2)
Other skin and subcutaneous diseases0.1
(0.0 to 0.1)
0.01%3.3
(-3.5 to 14.4)
Musculoskeletal disorders1.6
(1.4 to 1.6)
0.22%-0.1
(-4.4 to 3.2)
Rheumatoid arthritis0.6
(0.5 to 0.7)
0.08%-5.9
(-12.9 to -1.2)
Other musculoskeletal disorders1.0
(0.9 to 1.0)
0.14%3.9
(0.9 to 7.5)
Other non-communicable diseases16.3
(15.5 to 17.1)
2.21%-11.2
(-15.3 to -8.5)
Congenital anomalies 8.7
(8.2 to 9.2)
1.18%-18.2
(-24.7 to -14.1)
Neural tube defects0.9
(0.7 to 1.3)
0.12%-16.5
(-27.6 to -4.8)
Congenital heart anomalies3.9
(3.2 to 4.6)
0.53%-21.8
(-28.1 to -14.1)
Orofacial clefts0.1
(0.0 to 0.1)
0.01%-41.9
(-55.9 to -25.1)
Down's syndrome0.4
(0.3 to 0.5)
0.05%-5.2
(-14.2 to 7.0)
Other chromosomal abnormalities0.3
(0.2 to 0.4)
0.04%0.3
(-10.1 to 13.2)
Congenital musculoskeletal and limb anomalies0.2
(0.1 to 0.2)
0.03%-12.8
(-20.9 to -4.5)
Urogenital congenital anomalies0.2
(0.1 to 0.2)
0.03%-8.5
(-17.1 to 2.1)
Digestive congenital anomalies0.8
(0.6 to 1.1)
0.11%-19.3
(-29.8 to -9.8)
Other congenital anomalies2.1
(1.5 to 2.6)
0.28%-15.9
(-23.3 to -4.5)
Urinary diseases and male infertility 3.6
(3.5 to 3.7)
0.49%5.7
(2.2 to 8.5)
Urinary tract infections2.7
(2.6 to 3.0)
0.37%10.9
(7.2 to 14.5)
Urolithiasis (Kidney stone disease)0.2
(0.1 to 0.2)
0.03%-1.2
(-9.7 to 12.9)
Other urinary diseases0.7
(0.6 to 0.8)
0.09%-9.9
(-15.3 to -2.2)
Gynecological diseases 0.1
(0.1 to 0.1)
0.01%-2.6
(-13.6 to 6.0)
Uterine fibroids0.0
(0.0 to 0.0)
0.00%8.1
(-14.9 to 24.7)
Polycystic ovarian syndrome0.0
(0.0 to 0.0)
0.00%1.0
(-22.5 to 34.8)
Endometriosis0.0
(0.0 to 0.0)
0.00%-3.2
(-23.8 to 25.5)
Genital prolapse0.0
(0.0 to 0.0)
0.00%-24.1
(-36.0 to -13.0)
Other gynecological diseases0.1
(0.1 to 0.1)
0.01%-3.6
(-12.2 to 5.9)
Hemoglobinopathies and hemolytic anaemias 1.4
(1.1 to 1.8)
0.19%-11.3
(-17.6 to -4.8)
Thalassemias0.1
(0.1 to 0.1)
0.01%-27.9
(-36.5 to -17.2)
Sickle cell disorders0.5
(0.3 to 0.8)
0.07%-3.1
(-17.6 to 10.3)
G6PD deficiency0.2
(0.2 to 0.3)
0.03%-7.1
(-12.1 to -1.0)
Other hemoglobinopathies and hemolytic anaemias0.6
(0.5 to 0.6)
0.08%-16.1
(-18.7 to -13.4)
Endocrine, metabolic, blood, and immune disorders 1.9
(1.5 to 2.0)
0.26%0.8
(-5.0 to 4.4)
Sudden infant death syndrome 0.6
(0.3 to 1.2)
0.08%-20.2
(-31.2 to -4.9)
Injuries57.9
(55.9 to 59.2)
7.85%-13.7
(-15.1 to -12.2)
Transport injuries17.0
(16.4 to 17.4)
2.30%-17.0
(-19.5 to -14.9)
Road injuries 15.8
(15.2 to 16.3)
2.14%-17.1
(-19.7 to -14.9)
Pedestrian road injuries6.2
(5.9 to 6.8)
0.84%-21.4
(-25.5 to -17.9)
Cyclist road injuries0.9
(0.7 to 1.0)
0.12%-8.8
(-14.8 to -2.5)
Motorcyclist road injuries2.9
(2.5 to 3.0)
0.39%-12.4
(-19.5 to -7.3)
Motor vehicle road injuries5.8
(5.4 to 6.0)
0.79%-15.6
(-18.6 to -12.2)
Other road injuries0.1
(0.1 to 0.2)
0.01%-19.4
(-24.1 to -1.3)
Other transport injuries 1.2
(1.1 to 1.4)
0.16%-15.5
(-19.5 to -10.9)
Unintentional injuries23.8
(22.4 to 24.7)
3.23%-15.3
(-17.3 to -12.8)
Falls9.2
(8.5 to 9.8)
1.25%-2.8
(-7.4 to 3.4)
Drowning4.0
(3.8 to 4.1)
0.54%-27.3
(-29.6 to -24.5)
Fire, heat, and hot substances1.6
(1.3 to 1.7)
0.22%-22.9
(-25.4 to -17.3)
Poisonings0.9
(0.7 to 1.0)
0.12%-20.8
(-28.4 to -12.5)
(Poisoning by carbon monoxide0.5
(0.3 to 0.5)
0.07%-26.6
(-34.8 to -20.3)
(Poisoning by other means0.5
(0.4 to 0.5)
0.07%-14.4
(-22.4 to -3.9)
Exposure to mechanical forces1.8
(1.5 to 1.8)
0.24%-20.3
(-22.9 to -17.8)
(Unintentional firearm injuries0.3
(0.3 to 0.3)
0.04%-16.4
(-20.3 to -11.5)
(Other exposure to mechanical forces1.5
(1.2 to 1.6)
0.20%-21.0
(-23.7 to -18.3)
Adverse effects of medical treatment1.6
(1.4 to 1.8)
0.22%-6.2
(-10.0 to -2.5)
Animal contact1.1
(0.6 to 1.2)
0.15%-16.0
(-20.5 to -9.6)
(Venomous animal contact0.9
(0.5 to 1.1)
0.12%-16.0
(-21.0 to -9.7)
(Non-venomous animal contact0.1
(0.1 to 0.2)
0.01%-16.1
(-27.4 to -6.2)
Foreign body1.7
(1.6 to 1.8)
0.23%-14.1
(-17.0 to -11.6)
(Pulmonary aspiration and foreign body in airway1.6
(1.5 to 1.7)
0.22%-13.9
(-17.0 to -11.4)
(Foreign body in other body part0.1
(0.1 to 0.1)
0.01%-15.8
(-20.8 to -10.0)
Environmental heat and cold exposure0.7
(0.5 to 0.8)
0.09%-29.4
(-37.1 to -25.4)
Exposure to forces of nature0.1
(0.1 to 0.1)
0.01%-45.8
(-45.8 to -45.8)
Other unintentional injuries1.2
(1.2 to 1.3)
0.16%-25.8
(-27.6 to -23.8)
Self-harm and interpersonal violence17.1
(16.3 to 17.5)
2.32%-7.6
(-9.9 to -5.5)
Self-harm 10.0
(9.4 to 10.3)
1.36%-14.8
(-18.0 to -12.6)
Self-harm by firearm0.8
(0.7 to 1.0)
0.11%-10.3
(-13.9 to -7.2)
Self-harm by other specified means9.2
(8.5 to 9.5)
1.25%-15.2
(-18.4 to -12.8)
Interpersonal violence 5.2
(4.7 to 5.5)
0.70%-11.1
(-13.3 to -8.7)
Assault by firearm2.2
(1.9 to 2.4)
0.30%-3.6
(-6.5 to -0.5)
Assault by sharp object1.2
(0.9 to 1.4)
0.16%-22.3
(-25.6 to -17.6)
Assault by other means1.8
(1.6 to 2.1)
0.24%-11.5
(-15.4 to -7.6)
Conflict and terrorism 1.7
(1.7 to 1.7)
0.23%98.4
(98.4 to 98.5)
Executions and police conflict 0.2
(0.2 to 0.2)
0.03%172.4
(156.8 to 187.6)

Malnutrition

Malnutrition can be identified as an underlying cause for shortened life.[4] 70% of childhood deaths (age 0–4) are reportedly due to diarrheal illness, acute respiratory infection, malaria and immunizable disease. However 56% of these childhood deaths can be attributed to the effects of malnutrition as an underlying cause.[5] The effects of malnutrition include increased susceptibility to infection,[6] musculature wasting, skeletal deformities and neurologic development delays.[7] According to the World Health Organization, malnutrition is named as the biggest contributor to child mortality[8] with 36 million deaths in 2005 related to malnutrition.[9]

Developed vs. developing economies

Top causes of death, according to the World Health Organization report for the calendar year 2001:[10]

Causes of death in developing countriesNumber of deathsCauses of death in developed countriesNumber of deaths
HIV-AIDS2,678,000 Ischaemic heart disease3,512,000
Lower respiratory infections2,643,000 Cerebrovascular disease3,346,000
Ischaemic heart disease2,484,000 Chronic obstructive pulmonary disease1,829,000
Diarrhea1,793,000 Lower respiratory infections1,180,000
Cerebrovascular disease1,381,000 Lung cancer938,000
Childhood diseases1,217,000 Car crash669,000
Malaria1,103,000 Stomach cancer657,000
Tuberculosis1,021,000 Hypertensive heart disease635,000
Chronic obstructive pulmonary disease748,000 Tuberculosis571,000
Measles674,000 Suicide499,000

By age group

10 leading causes of death in the United States by age group 2015.[11]
Leading causes of death in the United States by age group.[12]
Leading causes of death in the United States, as percentage of deaths in each age group.[12] Perinatal mortality (<1yrs of age) seldom falls in any of these causes.
Death by age group as rate compared to the age group with highest rate.[12]

By occupation

With an average of 123.6 deaths per 100,000 from 2003 through 2010 the most dangerous occupation in the United States is the cell tower construction industry.[13]

Selected occupations with high fatality rates, 2011, in the United States.[14]

See also

References

  1. WHO (2005). "Cancer". Archived from the original on May 18, 2020.
  2. Lozano, Rafael; et al. (Dec 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010" (PDF). Lancet. 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. hdl:10536/DRO/DU:30050819. PMID 23245604. Archived from the original (PDF) on May 19, 2020.
  3. GBD 2017 Causes of Death Collaborators. "Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017". The Lancet. 8 Nov 2018; 392:1736–88. doi:10.1016/S0140-6736(18)32203-7. Table 1.
  4. "Mortality In Second And Third Degree Malnutrition". Tropej.oxfordjournals.org. 2014-06-03. Retrieved 2014-06-09.
  5. Pelletier DL, Frongillo EA, Schroeder DG, Habicht JP (2014-01-24). "The effects of malnutrition on child mortality in developing countries". Bull. World Health Organ. 73 (4): 443–48. PMC 2486780. PMID 7554015.
  6. "Some effects of malnutrition on the immune response in man". Ajcn.nutrition.org. 1974-06-01. Retrieved 2014-06-09.
  7. "Elsevier". Pediatric.theclinics.com. Retrieved 2014-06-09.
  8. Stay informed today; every day (2008-01-24). "Malnutrition: The starvelings". The Economist. Retrieved 2014-06-09.
  9. Ziegler, Jean (2007). L'Empire de la honte. Fayard
  10. "Cause of Death". UC Atlas of Global Inequality. University of California, Santa Cruz. 18 February 2004. Archived from the original on 18 June 2014. Retrieved 2014-06-09.
  11. "Leading causes of death by age group" (PDF). National Center for Injury Prevention and Control. 2015.
  12. "National Vital Statistics Report" (PDF). National Vital Statistics Report, Vol. 50, No. 15. September 16, 2002.
  13. Day, Ryan Knutson, Liz (21 May 2012). "Methodology: How We Calculated the Tower Industry Death Rate".
  14. "Bureau of Labor Statistics; National Census of Fatal Occupational Injuries in 2006" (PDF). Retrieved 2014-06-09.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.